Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
RenovoRx, Inc. - Common Stock
(NQ:
RNXT
)
0.9976
-0.0424 (-4.08%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RenovoRx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Top movers in Monday's pre-market session
↗
January 12, 2026
Via
Chartmill
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
January 08, 2026
From
Equity Insider
Via
GlobeNewswire
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
December 08, 2025
Via
ACCESS Newswire
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
Earnings Preview For RenovoRx
↗
May 14, 2025
Via
Benzinga
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
December 01, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 14, 2025
Via
Benzinga
RENOVORX INC (NASDAQ:RNXT) Reports Significant Q3 2025 Revenue Miss and 5% Stock Drop
↗
November 13, 2025
RenovoRx Q3 2025 earnings show a 35% revenue miss, causing a stock drop. The clinical-stage biopharma provided a 2026 growth outlook to offset cash burn.
Via
Chartmill
RenovoRx (RNXT) Q3 2025 Earnings Call Transcript
↗
November 13, 2025
RenovoRx (RNXT) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Economy
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 10, 2025
Via
Benzinga
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
September 16, 2025
Via
ACCESS Newswire
iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
September 09, 2025
Via
ACCESS Newswire
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge
↗
September 08, 2025
Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Wednesday?
↗
September 03, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025
August 20, 2025
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 15, 2025
Via
Benzinga
Gapping stocks in Friday's session
↗
August 15, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
What's going on in today's pre-market session
↗
August 15, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 15, 2025
Via
Benzinga
RenovoRx Revenue Jumps 28 Percent in Q2
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
RenovoRx Inc. (NASDAQ:RNXT) Q2 2025 Earnings: Revenue Surpasses Estimates, Shares Climb on Positive Results
↗
August 14, 2025
RenovoRx (NASDAQ:RNXT) Q2 2025 revenue beats estimates at $422K, shares rise 4.8%. RenovoCath adoption grows, Phase III trial progresses. Strong cash position supports operations.
Via
Chartmill
RenovoRx Reports Commercial Revenue Growth in the Second Quarter 2025 and Announces Positive Independent Data Monitoring Committee Recommendation to Continue Pivotal Phase III TIGeR-PaC Trial Based on Interim Data Review
August 14, 2025
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Launches Multi-Center Post-Marketing Registry Study to Evaluate Cancer Treatment Delivered by RenovoCath® Device to Solid Tumors
July 28, 2025
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET
July 14, 2025
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 27, 2025
Via
Benzinga
RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights
May 15, 2025
From
RenovoRx, Inc.
Via
Business Wire
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st
May 14, 2025
From
RenovoRx, Inc.
Via
Business Wire
U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform
May 06, 2025
From
RenovoRx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
